Dr Agarwal'S Eye Institute Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 47 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 375.08 Cr
as on 17-07-2024
- Revenue 498.51%
(FY 2023)
- Profit 21.02%
(FY 2023)
- Ebitda -45.83%
(FY 2023)
- Net Worth -0.06%
(FY 2023)
- Total Assets 0.05%
(FY 2023)
About Dr Agarwal'S Eye Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹375.08 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amar Agarwal, Athiya Agarwal, and Ashvin Agarwal serve as directors at the Company.
- CIN/LLPIN
U85110TN1977PTC007351
- Company No.
007351
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 1977
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Madras-86., Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr Agarwal'S Eye Institute?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashvin Agarwal  | Director | 19-May-2009 | Current |
Amar Agarwal  | Director | 20-Jul-1977 | Current |
| Athiya Agarwal | Director | 20-Jul-1977 | Current |
Financial Performance and Corporate Structure Insights of Dr Agarwal'S Eye Institute.
Dr Agarwal'S Eye Institute Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 498.51% increase. The company also saw a substantial improvement in profitability, with a 21.02% increase in profit. The company's net worth dipped by a decrease of 0.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Agarwal'S Eye Institute?
In 2023, Dr Agarwal'S Eye Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr. Agarwal's Eye Hospital LimitedActive 30 years 7 monthsAmar Agarwal and Athiya Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Trusteeship Services Limited Creation Date: 28 Nov 2019 | ₹215.00 Cr | Satisfied |
Idbi Trusteeship Services Limited Creation Date: 07 Jun 2017 | ₹160.00 Cr | Satisfied |
Bharat Overseas Bank Ltd. Creation Date: 28 Feb 1989 | ₹0.32 M | Satisfied |
How Many Employees Work at Dr Agarwal'S Eye Institute?
Dr Agarwal'S Eye Institute has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Agarwal'S Eye Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Agarwal'S Eye Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
